Literature DB >> 17123305

Accumulating quantitative trait linkage evidence across multiple datasets using the posterior probability of linkage.

Christopher W Bartlett1, Veronica J Vieland.   

Abstract

Genome scans for complex disorders are frequently inconclusive, prompting researchers to increase sample size in an effort to obtain stronger evidence. However, increasing sample size in the presence of locus heterogeneity may actually, on average, decrease the linkage signal at a true susceptibility gene. The posterior probability of linkage, or PPL, was specifically designed to address this issue in the context of categorical trait analysis, by appropriately accumulating evidence either for or against linkage as new data are added. We now formulate a quantitative trait (QT) analog, the QT-PPL, which directly measures the evidence that a QT is linked to a genetic marker or location. The new QT-PPL is based on a classical single-locus QT likelihood with the trait parameters (allele frequency, genotypic means and variances) integrated out. We show using simulations that the QT-PPL is robust to two key modeling violations (multiple trait loci and non-normality in the form of excess kurtosis), as well as being inherently ascertainment corrected, and illustrate the advantages of the QT-PPL for accumulating linkage evidence across multiple sets of data compared to other QT linkage methods.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17123305     DOI: 10.1002/gepi.20193

Source DB:  PubMed          Journal:  Genet Epidemiol        ISSN: 0741-0395            Impact factor:   2.135


  15 in total

1.  Expected monotonicity--a desirable property for evidence measures?

Authors:  Susan E Hodge; Veronica J Vieland
Journal:  Hum Hered       Date:  2010-07-21       Impact factor: 0.444

2.  Fast and accurate calculation of a computationally intensive statistic for mapping disease genes.

Authors:  Sang-Cheol Seok; Michael Evans; Veronica J Vieland
Journal:  J Comput Biol       Date:  2009-05       Impact factor: 1.479

3.  Practical considerations for dividing data into subsets prior to PPL analysis.

Authors:  M Govil; V J Vieland
Journal:  Hum Hered       Date:  2008-07-09       Impact factor: 0.444

4.  Evaluation of a bayesian model integration-based method for censored data.

Authors:  Liping Hou; Kai Wang; Christopher W Bartlett
Journal:  Hum Hered       Date:  2012-09-26       Impact factor: 0.444

5.  Increasing genotype-phenotype model determinism: application to bivariate reading/language traits and epistatic interactions in language-impaired families.

Authors:  Tabatha R Simmons; Judy F Flax; Marco A Azaro; Jared E Hayter; Laura M Justice; Stephen A Petrill; Anne S Bassett; Paula Tallal; Linda M Brzustowicz; Christopher W Bartlett
Journal:  Hum Hered       Date:  2010-10-14       Impact factor: 0.444

6.  A multilocus model of the genetic architecture of autoimmune thyroid disorder, with clinical implications.

Authors:  Veronica J Vieland; Yungui Huang; Christopher Bartlett; Terry F Davies; Yaron Tomer
Journal:  Am J Hum Genet       Date:  2008-05-15       Impact factor: 11.025

7.  Measurement of statistical evidence on an absolute scale following thermodynamic principles.

Authors:  V J Vieland; J Das; S E Hodge; S-C Seok
Journal:  Theory Biosci       Date:  2013-03-05       Impact factor: 1.919

8.  Employing MCMC under the PPL framework to analyze sequence data in large pedigrees.

Authors:  Yungui Huang; Alun Thomas; Veronica J Vieland
Journal:  Front Genet       Date:  2013-04-19       Impact factor: 4.599

9.  KELVIN: a software package for rigorous measurement of statistical evidence in human genetics.

Authors:  Veronica J Vieland; Yungui Huang; Sang-Cheol Seok; John Burian; Umit Catalyurek; Jeffrey O'Connell; Alberto Segre; William Valentine-Cooper
Journal:  Hum Hered       Date:  2011-12-23       Impact factor: 0.444

10.  miRNA-mediated risk for schizophrenia in 22q11.2 deletion syndrome.

Authors:  Linda M Brzustowicz; Anne S Bassett
Journal:  Front Genet       Date:  2012-12-13       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.